ArticleThe Psychiatric quarterly2015
Schizophrenia and Employment: Evaluation From Professionals Point of View.
Article in The Psychiatric quarterly, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- The Factors Affecting the Relationship between Remission Status and Employment in Chronic Schizophrenia Patients.Psychiatry investigation · 2019Article
- Opinions and Expectations Related to Job Placement of Individuals with Schizophrenia: A Qualitative Study Including Both Patients and Employers.Community mental health journal · 2019Article
- The economic burden of inpatient care of depression in Poznan (Poland) and Kiel (Germany) in 2016.PloS one · 2018Article
- Ethical Implications of the Mild Encephalitis Hypothesis of Schizophrenia.Frontiers in psychiatry · 2017Article
- Affordability of medicines in the European Union.PloS one · 2017Article
- The Cost of Inpatient Care of Schizophrenia and Treatment Schedules Used in German Academic Center: Kiel.The Psychiatric quarterly · 2016Article
- Bilingualism and schizophrenia.World journal of psychiatry · 2016Review
- Understanding the direct and indirect costs of patients with schizophrenia.F1000Research · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Schizophrenia is a severe and chronic disorder requiring long-lasting and comprehensive treatment. Because of this disorder patients are socially isolated. Consequently, schizophrenia has a significant economic burden both in a group of direct and indirect costs. The aim was to analyse experts' opinions in the field of psychiatry concerning work possibilities among people with schizophrenia and to present the importance of employment for more effective treatment. A worldwide study was conducted between June 2011 and June 2013 using a questionnaire consisting of six open-closed questions and a short metrics. The questionnaire was delivered to experts and spread all over the world by post and via the internet. Over 3000 questionnaires were sent and the addressed specialists were requested to return them. From received 403 questionnaires 320 were included into the study, based on adopted inclusion and exclusion criteria. Although patients are afraid of looking for a job, respondents indicated that they crave for employment. The number of people that are able to work during remission of schizophrenia is considerably higher (50.35 %) than the number of actually employed (15.85 %). Non-pharmacological therapies were indicated as important to improve patients' chances of finding a job during remission of schizophrenia. The number of people that can work during remission of schizophrenia is considerably higher than the number of affected people employed. Patients crave for a job and supported employment should be treated as priority by health-care decision makers.
Indexed as
Identifiers
25736799What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.